信息搜索
信息关键字：药
  

共有5246条记录

分页[首页] [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] [94] [95] [96] [97] [98] [99] [100] [101] [102] [103] [104] [105] [106] [107] [108] [109] [110] [111] [112] [113] [114] [115] [116] [117] [118] [119] [120] [121] [122] [123] [124] [125] [126] [127] [128] [129] [130] [131] [132] [133] [134] [135] [136] [137] [138] [139] [140] [141] [142] [143] [144] [145] [146] [147] [148] [149] [150] [151] [152] [153] [154] [155] [156] [157] [158] [159] [160] [161] [162] [163] [164] [165] [166] [167] [168] [169] [170] [171] [172] [173] [174] [175] [176] [177] [178] [179] [180] [181] [182] [183] [184] [185] [186] [187] [188] [189] [190] [191] [192] [193] [194] [195] [196] [197] [198] [199] [200] [201] [202] [203] [204] [205] [206] [207] [208] [209] [210] [211] [212] [213] [214] [215] [216] [217] [218] [219] [220] [221] [222] [223] [224] [225] [226] [227] [228] [229] [230] [231] [232] [233] [234] [235] [236] [237] [238] [239] [240] [241] [242] [243] [244] [245] [246] [247] [248] [249] [250] [251] [252] [253] [254] [255] [256] [257] [258] [259] [260] [261] [262] [263]

·恒瑞医药高管更迭两名新任副总负责临床研发2022-4-13 8:58:34
·外资转为净流入，买电新卖医药——市场温度计2022-4-13 8:05:44
·亿帆医药2021年净利2.78亿同比下滑71.25%董事长程先锋薪酬62.4万2022-4-13 7:11:44
·一飞药业2021年净利461.71万同比增长203.59%订单数量大幅增加2022-4-13 0:07:36
·上证科创板生物医药指数即将发布2022-4-12 23:28:53
·“硬科技+新消费”尽显成长性上证科创板生物医药指数即将发布2022-4-12 23:15:49
·上交所：5月9日正式发布上证科创板生物医药指数2022-4-12 23:15:40
·上证科创板生物医药指数5月9日发布50家公司入选指数样本“硬科技”属性突出2022-4-12 22:54:39
·泓博医药业绩不稳，盈利能力堪忧，屡遭行政处罚，内控问题凸显2022-4-12 21:09:03
·海创药业科创板上市：跌近30%复星与海创同力是股东2022-4-12 20:44:17
·赛升药业2022年第一季度预计净利1.02亿-1.15亿同比增加140%-170%联营企业收益增加2022-4-12 20:19:33
·2022年一季报正式“开演”，化工、医药板块公司大面积预喜2022-4-12 20:06:00
·“药”事当先微医“护航”上海居民用药需求2022-4-12 16:24:49
·2022年3月湖北新三板企业市值TOP100：宏源药业、恒进感应市值超30亿元2022-4-12 14:15:00
·泰恩康：子公司山东华铂凯盛主要从事化学药与生物制品的研发与生产、医药技术服务及技术转让等相关业务2022-4-12 13:32:33
·A股午盘52只股票涨停：国统股份7连板、大理药业5连板、宁波富达“地天板”2022-4-12 12:11:59
·午评：沪指震荡跌0.66%农业、医药等板块走低网游、旅游等板块表现活跃2022-4-12 11:46:43
·三只新股开盘破发，科创板唯捷创芯、海创药业跌超25%2022-4-12 11:13:30
·新冠药概念股震荡走低2022-4-12 11:00:40
·688046 药康生物 2022-04-12 发行2022-4-12 8:47:15

分页[首页] [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] [94] [95] [96] [97] [98] [99] [100] [101] [102] [103] [104] [105] [106] [107] [108] [109] [110] [111] [112] [113] [114] [115] [116] [117] [118] [119] [120] [121] [122] [123] [124] [125] [126] [127] [128] [129] [130] [131] [132] [133] [134] [135] [136] [137] [138] [139] [140] [141] [142] [143] [144] [145] [146] [147] [148] [149] [150] [151] [152] [153] [154] [155] [156] [157] [158] [159] [160] [161] [162] [163] [164] [165] [166] [167] [168] [169] [170] [171] [172] [173] [174] [175] [176] [177] [178] [179] [180] [181] [182] [183] [184] [185] [186] [187] [188] [189] [190] [191] [192] [193] [194] [195] [196] [197] [198] [199] [200] [201] [202] [203] [204] [205] [206] [207] [208] [209] [210] [211] [212] [213] [214] [215] [216] [217] [218] [219] [220] [221] [222] [223] [224] [225] [226] [227] [228] [229] [230] [231] [232] [233] [234] [235] [236] [237] [238] [239] [240] [241] [242] [243] [244] [245] [246] [247] [248] [249] [250] [251] [252] [253] [254] [255] [256] [257] [258] [259] [260] [261] [262] [263]